ANTIBODY FOR CELIAC DISEASE - ANVISA Registration 80003610602
Access comprehensive regulatory information for ANTIBODY FOR CELIAC DISEASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80003610602 and manufactured by INOVA DIAGNOSTICS, INC.. The registration is held by WERFEN MEDICAL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, EUROIMMUN AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80003610602
25351169140202185
02004662000165
Company Information
Dates and Status
Sep 02, 2021
VIGENTE
09/18/2025 19:00:01
ANTICORPO PARA DOENÇA CELÍACA
Família Autoteste Glúten
ZHEJIANG ORIENT GENE BIOTECH CO., LTD.
80113770055
Sep 15, 2025
ANTICORPO PARA DOENÇA CELÍACA
AESKUCARE® Gluten Related Disorders IgA
AESKU DIAGNOSTICS GMBH & CO. KG
80105220280
Jul 07, 2025
ANTICORPO PARA DOENÇA CELÍACA
Gliadin IgM
GA GENERIC ASSAYS GMBH
80464810926
Jul 07, 2025
ANTICORPO PARA DOENÇA CELÍACA
Família Glúten
IN VITRO DIAGNOSTICA LTDA
10303460561
Jun 30, 2025
ANTICORPO PARA DOENÇA CELÍACA
FAMÍLIA MAGLUMI® IgA Anti-DGP (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
81504790469
Mar 05, 2025

